Emyria Ltd
EMD•Health Care•Biotechnology•Last updated: Dec 25
About
Emyria Ltd is a clinical-stage biotech company focused on developing treatments for unmet medical needs. The company operates through segments including clinical trials and drug development, with a focus on cannabinoid-based medicines and data-driven healthcare solutions. Emyria leverages real-world evidence to advance its therapeutic programs and improve patient outcomes.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- EMD
Related Shares
Investor Resources
Should you buy Emyria Ltd right now?
While EMD looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now